Literature DB >> 9863542

LPS-induced cytokine production and expression of beta2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia.

C Rovers1, M G Netea, N de Bont, P N Demacker, C Jacobs, B J Kullberg, J W Van der Meer, A F Stalenhoef.   

Abstract

It has been suggested that proinflammatory cytokines such as tumor necrosis factor-alpha (TNF) and interleukin-1beta (IL-1), as well as adhesion molecules such as beta2-integrins and CD14, play a role in the pathogenesis of atherosclerosis. Familial hypercholesterolemia (FH) is an autosomal disease in which defective or absent LDL receptors are the cause for extreme LDL concentrations and early development of atherosclerosis. We studied lipopolysaccharide-induced cytokine production and the expression of adhesion molecules by mononuclear cells of three homozygous FH patients and compared them with first-degree relatives and healthy controls. There was a tendency towards increased cytokine production by cells of FH patients, whereas the expression of adhesion molecules was not modified compared to controls. In addition, LDL-apheresis inhibited IL-1 and TNF production and the expression of CD11a, CD11b, CD11c and CD14 by the mononuclear cells of FH patients and this may be an additional beneficial effect of LDL-apheresis apart of decreasing LDL concentrations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9863542     DOI: 10.1016/s0021-9150(98)00152-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  2 in total

Review 1.  Lipoprotein apheresis.

Authors:  Vijay G Bhoj; Bruce S Sachais
Journal:  Curr Atheroscler Rep       Date:  2015-07       Impact factor: 5.113

2.  Innate and Acquired Cellular Immunity in Children with Familial Hypercholesterolemia Treated with Simvastatin.

Authors:  Radosław Motkowski; Marek Alifier; Paweł Abramowicz; Jerzy Konstantynowicz; Bożena Mikołuć; Anna Stasiak-Barmuta
Journal:  J Clin Med       Date:  2022-05-22       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.